Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. SATB1 in Malignant T Cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Increased Suicide Risk in Patients with Hidradenitis Suppurativa

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Research Techniques Made Simple: Choosing Appropriate Statistical Methods for Clinical Research

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mice with epidermal filaggrin deficiency show increased immune reactivity to nickel

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Temporal changes in chromium allergy in Denmark between 2002 and 2017

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

In psoriasis patients, incidence rates of Crohn disease (CD) and ulcerative colitis (UC) have been increased in epidemiological studies and certain clinical trials, yet the association remains poorly understood. We studied a 20-year nationwide cohort of 235,038 Danish adults with psoriasis and a 1:1 matched reference group. Less than 1% of psoriasis patients developed CD or UC during follow-up. Incidence rates of CD were highest for younger women with psoriasis and patients with concurrent psoriatic arthritis, whereas men with psoriasis had particularly high incidence rates of UC compared with their non-psoriasis peers. Adjusted hazard ratios of CD were 1.84 (95% confidence interval [CI]= 1.47-2.29) and 2.38 (95% CI = 1.62-3.49) among psoriasis patients treated with topical and systemic nonbiologic therapy, respectively. No definite CD cases occurred during biologic therapy. For UC, adjusted hazard ratios were 1.49 (95% CI = 1.29-1.72), 1.51 (95% CI = 1.14-2.01), and 1.23 (95% CI = 0.39-3.86, P = 0.7197) for psoriasis patients receiving topical, systemic nonbiologic, and biologic therapy, respectively. Time to CD (but not UC) diagnosis was significantly longer for psoriasis patients compared with the general population, and patients receiving systemic treatment had the longest time to CD and UC. Psoriasis was associated with increased risk of CD and UC. Particular risk factors included sex and psoriatic arthritis.

OriginalsprogEngelsk
TidsskriftThe Journal of investigative dermatology
Vol/bind139
Tidsskriftsnummer2
Sider (fra-til)316-323
Antal sider8
ISSN0022-202X
DOI
StatusUdgivet - feb. 2019

ID: 56333605